NSS Symposia


Capture the fracture celebrating 10 years - Learnings and successes

Chairperson: K. Åkesson

  • Introduction – why Capture the Fracture is so important to IOF - C. Cooper
  • Best Practise framework – development and why organisational audits support FLSs becoming effective - K. Åkesson
  • Getting mapped – were we started and where we are now - T. Thomas
  • Development of patient level performance indicators – why and how - K. Javaid
  • Capture the fracture in the next decade - S. Ferrari
  • Summary & Conclusion -


Implementing Physical activity for older adults at risk in various and specific situations

Chairperson: M. Aubertin-Leheudre

  • Implementing physical activity as a care for older adults following in geriatric outpatient clinics - M. Aubertin-Leheudre
  • Implementing physical activity for comunity-dwelling, pre-disabled seniors during isolation periods (e.g. Covid 19 Pandemic) - F. Buckinx
  • Implementing physical activity for older adults in nursing homes - O. Bruyère


Build Better Bones: a multi-stakeholder informed website to support rehabilitation for people with osteoporosis

Chairperson: S. Silverman

  • Rehabilitation interventions in patients with osteoporosis and fragility fracture - O. Bruyère
  • Development of the Build Better Bones website to support rehabilitation for people with osteoporosis - D. Pinto


Combined and sequential therapies mostly recommended or to be avoided in clinical practice

Chairperson: B. Muzzi Camargos

  • Sequential and combined treatment: Concepts, Rationales and Guidelines - L. F. Vidal Neira
  • Combinations and sequences to be avoided - J. Carey
  • Successful Associations, Timing and Endpoints - B. Muzzi Camargos


Audit LATAM 2021. Epidemiology, costs and burden of osteoporosis and fragility fractures in Latin America

Chairperson: S. Cerdas Pérez

  • Introduction and demographic regional overview - S. Cerdas Pérez
  • Epidemiology and costs of fragility fractures in Latin America - P. Clark
  • Comparative situation and challenges for osteoporosis diagnosis among the participant Latin America countries - B. Muzzi Camargos
  • Access to pharmacological and non-pharmacological treatment in Latin America - C. Campusano
  • Approach to secondary fracture prevention. The LATAM experience - A. Medina


Osteoporosis and Challenges in its Management: Commonalities and differences in three different world regions- the Asia Pacific, Europe and Latin America

Chairpersons: P. Clark & O. D. Messina

  • Osteoporosis in the Asia Pacific. Challenges and solutions - M. Chandran
  • Fragility fractures in Europe: diagnosis and treatment in daily practice - W. F. Lems
  • Osteoporosis in Latin America. Challenges and Solutions - S. Cerdas Pérez


Ulcerative colitis as a paradigm of secondary osteoporosis

Chairperson: Y. Dionyssiotis

  • Osteoporosis in the context of ulcerative colitis - Y. Dionyssiotis
  • Pathogenesis of osteoporosis in the context of ulcerative colitis - I. Kostoglou-Athanassiou
  • Ulcerative colitis and ankylosing spondylitis - L. Athanassiou
  • Treatment of osteoporosis in the context of ulcerative colitis - P. Athanassiou


Osteosarcopenia School

Chairperson: I. Kostoglou

  • Osteosarcopenia School - Y. Dionyssiotis
  • Physical activity for treatment and rehabilitation in osteoporosis and sarcopenia - M. A. Lissens


Approaches to optimum bone health services in standard practice

Chairpersons: Y. El Miedany & T. Mathias

  • Osteoporosis, Fracture Prevention and Falls Risk Assessment – Closing the Gap between Treatment Guidelines and Clinical Practice - N. A. Gadallah
  • Sarcopenia assessment in standard clinical practice: Who, How and When? - M. Hassan
  • Using social media as a patient education tool: Is there a room for bone health educational hub? - Y. El Miedany


African Society for Bone Health: Towards Better Bone Health

Chairperson: Y. El Miedany

  • Osteoporosis: A major challenge in Africa - A. Kalla
  • Osteoporosis and HIV: an African perspective - F. Paruk
  • Fracture risk centric approach for the management of osteoporosis - M. Ngandeu
  • DXA scanning in clinical practice - A. El Maghraoui


Orthogeriatric care across Europe: Geriatricians vs. Orthopaedicians

Chairpersons: G. Bahat & A. Ranhoff

  • Assessment of older acute hip fracture patients: From the view of geriatricians - N. Muge Catikkas
  • The analysis of costs derived from hip fracture hospital attention - J. Tarazona Santabalbina
  • Orthogeriatric care in Turkey: From orthopaedicians’ view - T. Kizilkurt
  • What the orthopaedic surgeon can do to avoid morbidity and mortality following an osteoporotic fracture ? - C. Ojeda Thies


Imaging in musculoskeletal pathology: what should clinicians know?

Chairperson: A. Ionescu Răzvan

  • Practical aspects in the radiographic evaluation of inflammatory and degenerative arthropathies - C. Avram
  • Ultrasonography in Rheumatology: tricks and tips - F. Ananu Vreju
  • Magnetic resonance imaging (MRI) in musculoskeletal pathology - M. Bojinca
  • Molecular imaging in Rheumatology: the "new kid in town - R. A. Ionescu


The role of training education in the development of healthcare professionals for prevention and qualitative management of osteoporosis and other chronic musculoskeletal diseases

Chairperson: F. Kamberi

  • Training education to improve healthcare professionals knowledge and skills for prevention and quality management of osteoporosi - F. Kamberi
  • Encouraging the promotion of musculoskeletal training among healthcare professionals as a cost-effective method for the preventi - E. Sinaj
  • Evaluation of continuing education for health care professionals related to musculoskeletal diseases and osteoporosis during the - G. Sinanaj
  • Assessing the needs of nursing staff for training related to Osteoporosis and musculoskeletal diseases - B. Subashi


Covid-19, post Covid-19 disease. Limitation of human mobility, comorbidities and effects on musculoskeletal disease

Chairperson: I. Kostoglou-Athanassiou

  • Limitation of human mobility due to pandemics. From ancient times to the SARS-CoV-2 virus era - Y. Athanassiou
  • Covid-19 and post-Covid. The role of inflammation and musculoskeletal manifestations - L. Athanassiou
  • Covid-19, post-Covid. Mobility problems - Y. Dionyssiotis
  • Covid-19, post-Covid. Antiinflammatory therapeutic interventions - P. Athanassiou


COVID-19 and the Musculoskeletal System

Chairperson: Y. Gökçe-Kutsal

  • What are the effects of COVID-19 on skeletal muscle? - Y. Kirazli
  • Does COVID-19 have an impact on bone and joint? - Y. Gökçe-Kutsal
  • Management of musculoskeletal consequences in persons with post COVID-19 syndrome - A. A. Küçükdeveci


Pain and comorbid disorders: diagnosis and therapeutic approaches

Chairperson: O. Kurushina

  • Pain, Brain and Biomecaniks - A. Barulin
  • Patient with the Pain. Why sometimes we fail? - O. Kurushina
  • Biokinematic — a new approach to back pain relief - B. Kalinchenko
  • Pain management: non-pharmacological approaches - A. Drushlyakova


How to optimize monitoring in Osteoporosis?

Chairperson: S. Ferrari

  • Introduction - S. Ferrari
  • Why monitoring matters? - W. F. Lems
  • FLS pathway and how the Best Practice Framework capture monitoring - M. K. Javaid
  • BPF results - Z. Mohsin
  • Discussion on recommendations for monitoring framework for FLSs - All - Chaired by S. Ferrari


Balkan Peninsula -regional initiative

Chairperson: Radmila Matijevic & Gülistan Bahat

  • Introduction - Gulistan Bahat
  • Balkan Peninsula -regional initiative - Radmila Matijevic
  • Artificial intelligence solutions for osteoporosis management and perception of artificial intelligence - Ivo Dumic-Cule
  • The current situation in the approach to osteoporosis in older adults in Turkey: areas in need of improvement with a model for other populations - Meris Esra Bozkurt


The role of Vitamin D in rheumatic diseases

Chairpersons: L. F. Vidal Neira & O. D. Messina

  • Vitamin D in patients with fibromyalgia - L. F. Vidal Neira
  • Vitamin D in other chronic rheumatic diseases including rheumatoid arthritis (RA)ans systemic lupus Erythematosus - O. D. Messina


Phosphorus and human health

Chairperson: M. Miglinas

  • The Crosstalk between Bone, Kidney and Vasculature: New Insights - A. Cerkauskaite
  • New players in the Chronic Kidney Disease–Mineral and Bone Disorder - A. F. Perna
  • Phosphate and vascular calcification: implications for treatment - J. Voelkl


Covid-19 and post Covid-19 disease. Autoimmunity, musculoskeletal and psychosocial effects

Chairperson: P. Athanassiou

  • Pandemics. History, posttraumatic stress and social effects - Y. Athanassiou
  • Covid-19, autoimmunity and musculoskeletal diseases - L. Athanassiou
  • Covid-19, post-Covid and frailty - Y. Dionyssiotis
  • Covid-19 and post-Covid. Autoimmunity and endocrine diseases - I. Kostoglou-Athanassiou


Bone health in sports medicine at a glance

Chairperson: S. Tuzun

  • Low Energy Availability in Sports Syndrome (LEA-s) and Stress Fractures - U. Akarirmak
  • How to Assess Bone in Sports Medicine - J. Carey
  • How to Optimize Bone Health in Sports Medicine - S. Tuzun


Musculoskeletal Consequences of COVID-19

Chairpersons: P. Borman & B. Karaoğlan

  • Musculoskeletal Problems in post-COVID-19 period - P. Borman
  • Pain Management in Covid-19 - B. Duyur Çakıt
  • Sarcopenia: Postacute sequele of COVID 19 - A. Utkan Karasu


Beyond status quo: Achievements and aspirations of the Asia Pacific Fragility Fracture Alliance

Chairperson: D. Chan

  • Systematic review on outcomes of hip fractures in Asia Pacific - J. Close
  • Bridging the gap: Bone health education for specialists - R. Blank
  • Asia Pacific Fragility Fracture Alliance – Asia Pacific Osteoporosis and Fragility Fracture Society Collaboration - J.-K. Lee